Pegunigalsidase alfa
Pegunigalsidase alfa Uses, Dosage, Side Effects, Food Interaction and all others data.
Pegunigalsidase alfa is under investigation in clinical trial NCT02921620 (Study to Evaluate the Safety and EffIcacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry Disease).
| Trade Name | Pegunigalsidase alfa |
| Generic | Pegunigalsidase alfa |
| Pegunigalsidase alfa Other Names | Pegunigalsidase alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Pegunigalsidase alfa
